RecruitingNCT06616337

Patients Suffering From Emotional Dysregulation

Retrospective Study of the Acceptability and Effectiveness of a Dialectical Behavioral Therapy Group in Patients Suffering From Emotional Dysregulation (Borderline Personality Disorder, Bipolar Disorder and Adult ADHD)


Sponsor

University Hospital, Strasbourg, France

Enrollment

100 participants

Start Date

Nov 21, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Emotional dysregulation (ED) is a common syndrome in psychiatric disorders. It is characterized by intense emotions, easily triggered, and with significant psychological impact: explosions of anger, irritability, impulsivity, emotional lability, etc. It is systematic in borderline personality disorder, and observed in a majority of patients with bipolar disorder. (even in the interictal period), adult ADHD, or addictions. ED is a cause of psychological distress, suicidal behavior or non-suicidal self-injury, and impaired quality of life. Pharmacological treatments only very partially improve these symptoms. Psychotherapies aimed at reducing ED are poorly developed in France. Dialectical behavioral therapy is a therapy that has shown its effectiveness in ED of BPD. This is why the psychiatry and addiction center of the University Hospitals of Strasbourg has set up groups using this psychotherapeutic approach based on this technique for almost 3 years. This technique being very little practiced in France, and even less studied, we want to see if it is adapted to a French population not accustomed to this type of practice.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study looks at whether a specific group therapy program called GREMO — which uses Dialectical Behavior Therapy (DBT) techniques to help people manage intense emotions — is effective for people who struggle with emotional dysregulation. Researchers are reviewing data from patients who already participated in the program between 2018 and 2023. **You may be eligible if...** - You are 18 years old or older - You attended at least the first session of a GREMO group therapy program between January 1, 2018 and December 31, 2023 - You are okay with your past data being used for research purposes **You may NOT be eligible if...** - You have previously stated you do not want your personal data used for scientific research Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Service de Psychiatrie 2 - CHU de Strasbourg - France

Strasbourg, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06616337


Related Trials